Back
Results - Announcements
Gujarat Kidney & Super Speciality Ltd consolidated sales up 12.13% on year in Q2FY2026, net profit improved by 10.14%
14-Aug-2026, 09:36
Gujarat Kidney & Super Speciality Ltd share price inched up 0.48% to Rs 136.65 after the company's net profit expanded by 10.14% to Rs 5.32 crore, while revenue from operations increased 12.13% to Rs 34.29 crore in Q2FY26 over Q1FY26. The market capitalization of Hospital industry group stocks on BSE stood at Rs 5.19 lakh crore, rising 7.50%. It has slipped by 1.93% over last one week and spiked sharply by 28.90% in last one month while the market capitalization of Gujarat Kidney & Super Speciality Ltd has marginally improved by 1.67% and 0.44% in the same period respectively. Profit before tax (PBT) of Gujarat Kidney & Super Speciality Ltd stood at Rs 6.96 crore in Q2 FY26, declining 7.08% year-on-year, and expanding by 48.40% quarter-on-quarter. EBITDA came in at Rs 8 crore, dropping 10.69% YoY and surging by 37.57% sequentially. Total expenses grew marginally by 6.05% to Rs 27.35 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 4.34 crore, witnessing a sharp rise of 28.78% YoY, while employee benefits expense was at Rs 5.29 crore, registering a marginal contraction of 1.12% YoY. For the TTM ended FY26, revenue from operations soared by 743.61% to Rs 40.24 crore, while net profit surged by 455.56% to Rs 9.5 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 322% to Rs 16.4 crore, and PBT surged 462.56% to Rs 12.77 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 13.61 crore in FY26, as against Rs 1.21 crore in FY25. Gujarat Kidney & Super Speciality Ltd jumped 29.96% in last one year, significantly outperforming the benchmark BSE Sensex which has eased by 3.05% during the same period.
Gujarat Kidney & Super Speciality Ltd share price inched up 0.48% to Rs 136.65 after the company's net profit expanded by 10.14% to Rs 5.32 crore, while revenue from operations increased 12.13% to Rs 34.29 crore in Q2FY26 over Q1FY26. The market capitalization of Hospital industry group stocks on BSE stood at Rs 5.19 lakh crore, rising 7.50%. It has slipped by 1.93% over last one week and spiked sharply by 28.90% in last one month while the market capitalization of Gujarat Kidney & Super Speciality Ltd has marginally improved by 1.67% and 0.44% in the same period respectively. Profit before tax (PBT) of Gujarat Kidney & Super Speciality Ltd stood at Rs 6.96 crore in Q2 FY26, declining 7.08% year-on-year, and expanding by 48.40% quarter-on-quarter. EBITDA came in at Rs 8 crore, dropping 10.69% YoY and surging by 37.57% sequentially. Total expenses grew marginally by 6.05% to Rs 27.35 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 4.34 crore, witnessing a sharp rise of 28.78% YoY, while employee benefits expense was at Rs 5.29 crore, registering a marginal contraction of 1.12% YoY. For the TTM ended FY26, revenue from operations soared by 743.61% to Rs 40.24 crore, while net profit surged by 455.56% to Rs 9.5 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 322% to Rs 16.4 crore, and PBT surged 462.56% to Rs 12.77 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 13.61 crore in FY26, as against Rs 1.21 crore in FY25. Gujarat Kidney & Super Speciality Ltd jumped 29.96% in last one year, significantly outperforming the benchmark BSE Sensex which has eased by 3.05% during the same period.